Hematology: Radiation Therapy of Brain for Acute Myeloid Leukemia (AML) with Brain Damage
Acute myeloid leukemia (AML) affects not only the bone marrow. Once in the blood, the tumor cells gradually spread throughout the body. Brain membrane impairment, or else neuroleukemia, can be a threatening complication of the disease. Treatment of such patients is carried out by radiation therapy.
The severity of brain structure damage is determined during survey. During the first visit, the physician examines the patient, collects his/her case history and prescribes a set of tests:
- complete blood count,
- blood chemistry,
- cytogenetic analysis,
- CT/MRI of the head.
Based on the diagnostics findings, the professional decides on the need in radiation. The patient is explained the goals of therapy, risks of side effects and measures to prevent the same.
The patient is admitted to a hospital for up to 31 days. Radiotherapy sessions are carried out daily for a few minutes. Ionizing radiation doses are selected individually, taking into account the age and general condition of the patient. The total cost of medication will depend on the cycle intensity and treatment duration.
The procedures are performed in the radiological room. The patient is placed on a special table, under which there is placed a radiation installation. Irradiation is performed from the lateral fields of the head field, 2 cm away from its surface. The healthy parts of the body are covered by shields during the session.
As regards side effects, the patients may report:
- increased body temperature,
- hair loss,
- dyspeptic disorders (nausea, vomiting).
In order to mitigate the adverse effects, a symptomatic therapy is prescribed. The clinic staff provides a careful patient care.
After course completion, the oncologist conducts examination and provides recommendations for further treatment.Hide
Haven't found Your diagnosis yet?
Send an inquiry to get a cost estimate on: